Pharmaceutical News and Articles

Histologic Response Up With Benralizumab for Eosinophilic Esophagitis

Benralizumab yields a greater histologic response than placebo for patients with eosinophilic esophagitis, but does not affect dysphagia symptoms, according to

Atogepant Efficacious for Patients With Chronic Migraine

For patients with chronic migraine (CM), with and without medication overuse, atogepant is efficacious, according to a study published online June 27 in Neurolo

Echocardiogram Can ID Women With Preeclampsia at Risk for Future HTN

Echocardiography during pregnancy or early postpartum can assist in identifying women with preeclampsia at greater risk of future hypertension, according to a s

Lower Risk of ALS Seen for Men With High Levels of Physical Activity, Fitness

For men, high levels of physical activity and fitness are associated with reduced risk of amyotrophic lateral sclerosis (ALS), according to a study published on

FDA Approves Ohtuvayre (ensifentrine) for the Maintenance Treatment of Chronic Obstructive Pulmonary Disease (COPD)

Anxiety Tied to Doubling of Parkinson's Risk

Anxiety could be an early warning sign of Parkinson s disease, a new study finds. People with anxiety have at least double the risk of developing Parkinson s co

Glofitamab + GemOx Superior to Rituximab + GemOx for Lymphoma

Glofitamab (Glofit) plus gemcitabine and oxaliplatin (GemOx) is superior to rituximab (R)-GemOx for relapsed refractory (R R) diffuse large B-cell lymphoma (DLB

CDC: Dengue Fever Cases Expected to Rise in the United States This Summer

On Tuesday, the U.S. Centers for Disease Control and Prevention issued a health advisory warning of a heightened risk of dengue fever infections in the United S

Multivitamin Use Not Linked to Mortality Benefit in U.S. Adults

Multivitamin (MV) use is not associated with mortality benefit among U.S. adults, according to a study published online June 26 in JAMA Network Open. Erikka Lof

Fatigue With Rheumatoid Arthritis Tied to Disease Activity, Education Level

The Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire (BRAF-MDQ) and Brief Fatigue Inventory (BFI-C) scores show consistency in assessing fat